Search Results for

Clear All Filters

May 09, 2022

Max Moran

Newsletter

Corporate Crackdown

CORPORATE CRACKDOWN UPDATES: 5/9/22

Closing in on toxins, the EPA is ramping up its enforcement by banning the use of weedkiller diuron and increasing its detection of PFAS chemicals in public water. Plus, the SEC’s new ‘Cyber Unit’ and DOL officials are keeping a close eye on the inclusion of cryptocurrency in Fidelity’s 401k plan.

April 25, 2022 | The American Prospect

Max Moran Fatou Ndiaye

Op-Ed

Congressional OversightPharma

Where's The Congressional Champion On Pharma Patent Abuses?

But for all of this, neither party’s congressional leaders have directly challenged the main legal mechanism that accounts for those high costs—namely, intellectual property. You’d think members of Congress would recognize the political salience of picking a fight with one of the most hated industries in America. So why isn’t anyone on Capitol Hill even talking about intellectual property’s role in driving high drug prices, and taking the PTO to task to do something about it?